Immune regulation by Tim-3 [version 1; referees: 2 approved]

T-cell immunoglobulin and mucin domain 3 (Tim-3) is a transmembrane protein that in both mice and humans has been shown to possess various functions in a context-dependent manner. Thus, Tim-3 has been associated with both inhibitory and co-stimulatory function, depending in part on the specific cell...

Full description

Bibliographic Details
Main Authors: Hridesh Banerjee, Lawrence P. Kane
Format: Article
Language:English
Published: F1000 Research Ltd 2018-03-01
Series:F1000Research
Online Access:https://f1000research.com/articles/7-316/v1
id doaj-cc1e1f9116d94e14ab6701135844b45e
record_format Article
spelling doaj-cc1e1f9116d94e14ab6701135844b45e2020-11-25T03:06:39ZengF1000 Research LtdF1000Research2046-14022018-03-01710.12688/f1000research.13446.114602Immune regulation by Tim-3 [version 1; referees: 2 approved]Hridesh Banerjee0Lawrence P. Kane1Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15261, USADepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15261, USAT-cell immunoglobulin and mucin domain 3 (Tim-3) is a transmembrane protein that in both mice and humans has been shown to possess various functions in a context-dependent manner. Thus, Tim-3 has been associated with both inhibitory and co-stimulatory function, depending in part on the specific cell type and immune response course. Though originally described on T cells, Tim-3 is now known to be expressed by both lymphoid and non-lymphoid cells within the immune system and even by non-immune cells. In addition, though widely thought of as a negative regulator of immunity, Tim-3 has been shown in more recent studies to have a positive function on both myeloid and lymphoid cells, including T cells. Tim-3 is often expressed at a high level on exhausted T cells in tumors and chronic infection and may engage in crosstalk with other so-called “checkpoint” molecules such as PD-1. Thus, Tim-3 has emerged as a possible therapeutic target, which is being actively explored both pre-clinically and clinically. However, recent research suggests a more complex in vivo role for this protein, compared with other targets in this area.https://f1000research.com/articles/7-316/v1
collection DOAJ
language English
format Article
sources DOAJ
author Hridesh Banerjee
Lawrence P. Kane
spellingShingle Hridesh Banerjee
Lawrence P. Kane
Immune regulation by Tim-3 [version 1; referees: 2 approved]
F1000Research
author_facet Hridesh Banerjee
Lawrence P. Kane
author_sort Hridesh Banerjee
title Immune regulation by Tim-3 [version 1; referees: 2 approved]
title_short Immune regulation by Tim-3 [version 1; referees: 2 approved]
title_full Immune regulation by Tim-3 [version 1; referees: 2 approved]
title_fullStr Immune regulation by Tim-3 [version 1; referees: 2 approved]
title_full_unstemmed Immune regulation by Tim-3 [version 1; referees: 2 approved]
title_sort immune regulation by tim-3 [version 1; referees: 2 approved]
publisher F1000 Research Ltd
series F1000Research
issn 2046-1402
publishDate 2018-03-01
description T-cell immunoglobulin and mucin domain 3 (Tim-3) is a transmembrane protein that in both mice and humans has been shown to possess various functions in a context-dependent manner. Thus, Tim-3 has been associated with both inhibitory and co-stimulatory function, depending in part on the specific cell type and immune response course. Though originally described on T cells, Tim-3 is now known to be expressed by both lymphoid and non-lymphoid cells within the immune system and even by non-immune cells. In addition, though widely thought of as a negative regulator of immunity, Tim-3 has been shown in more recent studies to have a positive function on both myeloid and lymphoid cells, including T cells. Tim-3 is often expressed at a high level on exhausted T cells in tumors and chronic infection and may engage in crosstalk with other so-called “checkpoint” molecules such as PD-1. Thus, Tim-3 has emerged as a possible therapeutic target, which is being actively explored both pre-clinically and clinically. However, recent research suggests a more complex in vivo role for this protein, compared with other targets in this area.
url https://f1000research.com/articles/7-316/v1
work_keys_str_mv AT hrideshbanerjee immuneregulationbytim3version1referees2approved
AT lawrencepkane immuneregulationbytim3version1referees2approved
_version_ 1724673125159796736